Raghu Kumar
Senior Scientist Ionis Pharmaceuticals, Inc.
Dr. Raghu Penke has over 15 years of experience in pulmonary disease research, this speaker specializes in target identification, in vivo validation, and translational models of lung fibrosis, asthma, and cancer. Dr. Penke brings deep expertise in single-cell and transcriptomic platforms, drug delivery systems, including a patented liposomal platform, and fibroblast-based high-throughput screening. His work spans academic-industrial collaborations and NIH-funded research, with 25+ peer-reviewed publications and extensive mentorship. His focus on lung organoids and mechanistic insight into tissue injury, immune response, and fibrotic progression positions them at the forefront of respiratory therapeutic development.
Seminars
- Leveraging gene and RNA-based therapies to address underlying disease drivers beyond traditional antifibrotics
- Advancing innovative delivery systems to enhance lungspecific targeting while ensuring patient safety
- Assessing the current landscape of gene and RNA therapies in IPF and the path to regulatory and clinical success
